We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current LIVN market cap is 3.39B. The company's latest EPS is USD 0.3290 and P/E is 191.25.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 252.61M | 274.87M | 263.42M | 293.88M | 286.11M |
| Operating Income | -131.97M | 13.96M | -2.34M | 17.38M | 4.46M |
| Net Income | -107.34M | 1.66M | 7.37M | 1.16M | -7.32M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.08B | 934.24M | 1.04B | 1.02B | 1.15B |
| Operating Income | -168.51M | -89.7M | -61.02M | -76.75M | 23.02M |
| Net Income | -155.18M | -345.01M | -135.82M | -86.25M | 17.75M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.21B | 2.29B | 2.29B | 2.34B | 2.33B |
| Total Liabilities | 1.07B | 1.09B | 1.07B | 1.1B | 1.1B |
| Total Equity | 1.15B | 1.21B | 1.23B | 1.24B | 1.23B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.41B | 2.41B | 2.2B | 2.29B | 2.43B |
| Total Liabilities | 1.03B | 1.29B | 906.31M | 1.09B | 1.15B |
| Total Equity | 1.38B | 1.12B | 1.29B | 1.21B | 1.28B |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 51.22M | 69.92M | 20.76M | 2.82M | 20.96M |
| Investing | -27.46M | -38.41M | -11.48M | -18.14M | -28.19M |
| Financing | 281.79M | 280.13M | -5.24M | 30.78M | 26.5M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -91.14M | -79.42M | 102.54M | 69.92M | 74.91M |
| Investing | -41.29M | -41.84M | 36.9M | -38.41M | -40.33M |
| Financing | 146.58M | 310.76M | -181.48M | 280.13M | 21.48M |
| Market Cap | 3.39B |
| Price to Earnings Ratio | 191.25 |
| Price to Sales Ratio | 2.94 |
| Price to Cash Ratio | 12.74 |
| Price to Book Ratio | 2.66 |
| Dividend Yield | - |
| Shares Outstanding | 53.96M |
| Average Volume (1 week) | 1.05M |
| Average Volume (1 Month) | 732.48k |
| 52 Week Change | 32.49% |
| 52 Week High | 63.21 |
| 52 Week Low | 42.75 |
| Spread (Intraday) | 12.24 (18.83%) |
| Company Name | LivaNova PLC |
| Address |
20 eastbourne terrace london W2 6LG |
| Website | https://www.livanova.com |
| Industry | electromedical apparatus (3845) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
